AC Immune Reports Q1 2019 Financial Results and Business Update
AC Immune SA, a Swiss-based, biopharmaceutical company with a broad clinical-stage pipeline focused on pioneering Precision Medicine in eurodegenerative diseases, today announced financial results for the first quarter ended March 31, 2019.